Anticancer Effects of Ginsenoside Rh2: A Systematic Review

Area of Science:

• Pharmacology
• Natural Products
• Oncology

Background:

• Ginsenoside Rh2 (Rh2) is a key active component derived from Ginseng Radix et Rhizoma.
• Rh2 demonstrates significant anticancer properties against diverse cancer cell lines in vitro.
• It effectively inhibits tumor growth in vivo with a favorable safety profile.

Purpose of the Study:

• To comprehensively review and synthesize existing evidence on the anticancer effects of Rh2.
• To elucidate the mechanisms underlying Rh2's therapeutic actions.
• To assess the potential for clinical application of this natural compound.

Main Methods:

• Literature review of preclinical and clinical studies on ginsenoside Rh2.
• Analysis of data on Rh2's impact on cancer cell proliferation, apoptosis, and metastasis.
• Evaluation of studies investigating Rh2's role in modulating drug resistance and immune responses.

Main Results:

• Rh2 induces cancer cell cycle arrest and promotes programmed cell death (apoptosis).
• It effectively suppresses cancer cell metastasis and invasion.
• Rh2 has shown potential in overcoming multidrug resistance and regulating the immune system.

Conclusions:

• Ginsenoside Rh2 exhibits multifaceted anticancer mechanisms, including cell cycle regulation, apoptosis induction, and immune modulation.
• Rh2 represents a promising natural product for cancer therapy with potential for broader clinical use.
• Further research into Rh2's application prospects is warranted.